Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy
Clinical trial NCT00001440 · COMPLETED
Trial details
- NCT number
- NCT00001440
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 1995-07-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.